Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) – Stock analysts at HC Wainwright upped their Q3 2026 earnings estimates for shares of Context Therapeutics in a research report issued to clients and investors on Thursday, August 6th. HC Wainwright analyst E. Bodnar now forecasts that the company will earn ($0.07) per share for the quarter, […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | What is HC Wainwright’s Forecast for Biodesix Q3 Earnings? | 0 | 12.55 | 10-08-2026 |
| 2 | Research Analysts Offer Predictions for CMPX Q3 Earnings | 0 | 11.48 | 10-08-2026 |
| 3 | HC Wainwright Has Positive Forecast for ARQT Q3 Earnings | 0 | 11.13 | 10-08-2026 |
| 4 | HC Wainwright Has Optimistic Outlook of TNYA FY2026 Earnings | 0 | 11.9 | 10-08-2026 |
| 5 | What is HC Wainwright’s Estimate for PTGX FY2026 Earnings? | 0 | 13.4 | 10-08-2026 |
| 6 | HC Wainwright Issues Pessimistic Outlook for SABS Earnings | 0 | 12.58 | 10-08-2026 |
| 7 | Q3 EPS Estimates for CG Oncology Lowered by HC Wainwright | 0 | 11.48 | 10-08-2026 |
| 8 | HC Wainwright Has Weak Forecast for Cytosorbents Q1 Earnings | 0 | 11.13 | 10-08-2026 |
| 9 | HC Wainwright Weighs in on Delcath Systems Q1 Earnings | 0 | 10.45 | 10-08-2026 |
| 10 | Conduent (NASDAQ:CNDT) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS | 0 | 15.17 | 10-08-2026 |